The FTSE 100 index was up 55.79 points, 0.7%, at 8,552.59. The FTSE 250 was up 0.94 points at 20,135.91, and the AIM All-Share was up 3.95 points, 0.6%, at 703.93.

(Alliance News) - Keir Starmer conceded Labour's loss by just six votes to Reform UK in the Runcorn and Helsby by-election was "disappointing" and said the UK government needed to go "further and ...

(Alliance News) - Apax Global Alpha Ltd on Friday said it is well positioned to deal with macroeconomic challenges, despite a dip in net asset value in the first quarter. Apax Global Alpha is a closed ...

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

The London-based oil and gas firm holds a 15% stake in the project, which will use two Golar LNG vessels - the Hilli Episeyo and MK II - to process and export around 6 million tonnes of LNG per year, ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

(Alliance News) - A cutting-edge new British drone will come into operation on Friday as Keir Starmer vowed that the UK government would "stand up to Putin and ruthlessly protect UK and European ...

(Alliance News) - Rotork PLC on Friday said first-quarter order intake rose year-on-year across all divisions, though revenue dipped slightly due to order book phasing and a strong comparator period.

The requisition calls for the removal of CEO Joe McTaggart and Non-Executive Director Ross Taylor, and for the appointment of Mark Taylor, director and controlling shareholder of Venture Finance, to ...

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Deutsche Bank Research raises London Stock Exchange price target to 12,900 (12,600 ...

Wizz Air reported 11% growth in passenger numbers to 5.4 million in April from 4.9 million a year prior. The Budapest-based budget airline said its capacity rose 11% also to 6.1 million from 5.4 ...

The Cambridge, England-based pharmaceutical company said its Kalos and Logos phase 3 trials showed Breztri achieved statistically significant and clinically meaningful improvements in lung function ...